Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung CancerTony Mok, Vassiliki A. Papadimitrakopoulou, Hye Ryun Kim et al.|New England Journal of Medicine|2016Cited by 3.3k
Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-AnalysisChee Khoon Lee, James Chih‐Hsin Yang, Johnathan Man et al.|Journal of Thoracic Oncology|2016Cited by 842
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung CarcinomaChee Khoon Lee, James Chih‐Hsin Yang|JAMA Oncology|2017Cited by 632